Gilead Sciences, Inc. (TSX:GILD)
Canada · Delayed Price · Currency is CAD 25.16
+0.43 (1.74%)
At close: Jan 12, 2026
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of CAD 208.78 billion as of January 12, 2026. Its market cap has increased by 23.93% in one year.
Market Cap
208.78B
Enterprise Value
228.74B
Revenue
40.51B
Ranking
n/a
PE Ratio
18.48
Stock Price
25.16
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 289.43M to 208.78B, an increase of 72,034.18%. That is a compound annual growth rate of 21.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 210.99B | 1.05% |
| Dec 31, 2025 | 208.80B | 26.06% |
| Dec 31, 2024 | 165.64B | 24.25% |
| Dec 29, 2023 | 133.31B | -8.53% |
| Dec 30, 2022 | 145.73B | 26.44% |
| Dec 31, 2021 | 115.26B | 23.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.70B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.07B |
| Trulieve Cannabis | 2.05B |
| Sienna Senior Living | 2.00B |
| Cronos Group | 1.43B |
| WELL Health Technologies | 1.07B |